Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Europe midday: Travel and leisure issues rally on hopes of vaccine breakthrough

Wed 15 July 2020 14:12 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

Market latest

FTSE 100 | FTSE 250 | Paris CAC 40 | Dow Jones | NASDAQ

5822.78 | Negative 76.48 (1.30%)

Prices delayed by at least 15 minutes

(Sharecast News) - Stocks in Europe appear to be attempting a breakout to multi-month highs amid reports that positive news around Oxford University's Covid-19 vaccine candidate was imminent.

According to ITV's Richard Peston, "positive" preliminary data from that vaccine trials could be published in the Lancet on Thursday.

ITV further reported that, unlike many other vaccines, the one being developed at Oxford's Jenner Institute appeared to trigger both a significant antibody as well as T-cell response.

As of 1343 BST, Germany's Dax had topped its June highs and was ahead by 1.84% to 12,931.47 alongside a 2.49% advance for the French Cac-40 to 5,132.09, while the FTSE Mibtel was up by 2.1% at 20,297.86.

Pacing gains was the Stoxx 600's Travel&Leisure sub-index which was bounding ahead by 4.76% - although it remained well beneath the June highs.

Shares of IAG, Carnival and RyanAir were all near the top of the Stoxx 600 leaderboard, but the best performer was Atlantia SpA.

Earlier, toll-road operator Autostrade, which is majority owned by Atlantia, had tabled two fresh proposals to the government in Rome aimed at breaking their long-running dispute following the tragic 2018 collapse of a motorway bridge in Genoa.

In parallel, euro/dollar was edging higher by 0.33% to 1.1438.

To take note of, stocks had already started the session on the front foot following news of positive clinical trial data for another front-runner in the race to defeat Covid-19, US-based Moderna Therapeutics.

No major economic data were scheduled for release on the Continent.

    Daily market update emails

    • FTSE 100 riser and faller updates
    • Breaking market news, plus the latest share research, tips and broker comments

    Register now for free market updates

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.